SG/PUT/MODERNA/120/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 15:36:04 2024-06-28 EDT | ||
| 1.99 EUR | +5.85% |
|
| Current month | +50.00% | ||
| 1 month | +73.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MODERNA, INC.
Latest news about MODERNA, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 1.98 | +5.32% |
| 24-06-27 | 1.88 | +1.62% |
| 24-06-26 | 1.85 | +30.28% |
| 24-06-25 | 1.42 | 0.00% |
| 24-06-24 | 1.42 | -6.58% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 03:36 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MODERNA, INC. |
| Issuer | 
Société Générale
|
| WKN | SU6Q5C |
| ISIN | DE000SU6Q5C5 |
| Date issued | 2024-01-08 |
| Strike | 120 $ |
| Maturity | 2025-03-21 (265 Days) |
| Parity | 10 : 1 |
| Emission price | 2.87 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.9 € |
|---|---|
| Lowest since issue | 0.91 € |
| Delta | -0.38x |
| Omega | 2.104 |
| Premium | 16.94x |
| Gearing | 5.56x |
| Moneyness | 1.011 |
| Difference Strike | 1.25 $ |
| Difference Strike % | +1.04% |
| Spread | 0.01 € |
| Spread % | 0.50% |
| Theoretical value | 1.995 |
| Implied Volatility | 58.50 % |
| Total Loss Probability | 42.46 % |
| Intrinsic value | 0.1167 |
| Present value | 1.878 |
| Break even | 98.63 € |
| Theta | -0.02x |
| Vega | 0.04x |
| Rho | -0.05x |
Company Profile
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
Consensus: Moderna, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
118.8
USD
Average target price
145.9
USD
Spread / Average Target
+22.82%
- Stock Market
- Warrants
- Warrant
